DYN
Dyne Therapeutics Receives European Medicines Agency (EMA) Orphan Drug Designation for DYNE-101
Thursday, May 25, 2023 1 min read
Key Takeaway: Dyne Therapeutics Receives European Medicines Agency (EMA) Orphan Drug Designation for DYNE-101
Full Press Release Details
Dyne Therapeutics Receives European Medicines Agency (EMA) Orphan Drug Designation for DYNE-101.